analyst
VE
NASDAQ · VERA
Vera Therapeutics, Inc.
Healthcare · Biotechnology
$33.67
Down-$1.89 (-5.63%)
Updated Sep 16, 2026, 6:19 PM
SID Score
4.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 2.94B
- P/E ratio
- -13.44
- Dividend yield
- 0.00%
- 52-week range
- $28.86 – $47.00
- Volume
- 10.49M
- Avg. volume
- 1.59M
Price performance
VERA price history
1M range · 20 trading sessions · Daily adjusted prices
VERA closed at $33.67 after 20 trading sessions, up 4.31% for the selected period.
- Last close
- $33.67
- Period change
- +4.31%
- Period low
- $31.26
- Period high
- $36.82
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $37.14 | $37.14 | $32.73 | $33.67 | 10.49M |
| Sep 14, 2026 | $35.11 | $35.535 | $33.22 | $34.05 | 1.71M |
| Sep 11, 2026 | $33.91 | $35.29 | $33.75 | $35.05 | 3.8M |
| Sep 10, 2026 | $33.49 | $34.29 | $32.88 | $33.60 | 2.03M |
| Sep 9, 2026 | $34.84 | $35.4829 | $33.75 | $33.78 | 939.21K |
| Sep 8, 2026 | $35.80 | $35.995 | $34.885 | $35.28 | 1.44M |
| Sep 4, 2026 | $34.69 | $36.41 | $34.69 | $35.89 | 1.18M |
| Sep 3, 2026 | $35.53 | $35.74 | $34.53 | $34.99 | 929.05K |
| Sep 2, 2026 | $34.44 | $35.73 | $33.8107 | $35.66 | 1.76M |
| Sep 1, 2026 | $33.73 | $34.40 | $33.65 | $34.23 | 4.07M |
| Aug 31, 2026 | $33.64 | $34.38 | $33.18 | $34.08 | 1.54M |
| Aug 28, 2026 | $34.40 | $34.47 | $33.34 | $34.19 | 1.26M |
| Aug 27, 2026 | $36.70 | $36.70 | $34.10 | $34.60 | 2.78M |
| Aug 26, 2026 | $35.10 | $36.96 | $34.6401 | $36.82 | 2.38M |
| Aug 25, 2026 | $34.05 | $35.57 | $34.00 | $35.28 | 2.49M |
| Aug 24, 2026 | $32.25 | $35.0917 | $32.02 | $33.72 | 2.41M |
| Aug 21, 2026 | $31.42 | $32.97 | $31.0331 | $32.275 | 1.29M |
| Aug 20, 2026 | $32.295 | $32.295 | $30.72 | $31.26 | 1.56M |
| Aug 19, 2026 | $32.88 | $33.48 | $31.70 | $32.275 | 1.26M |
| Aug 18, 2026 | $31.31 | $32.3499 | $31.31 | $32.28 | 1.03M |
Latest VERA news
The latest Smart Investors Daily articles mentioning VERA.
Stock researchCompany · Financials
Loading stock research…